10X Genomics Inc (TXG)

NASDAQ
31.66
+2.35(+8.02%)
After Hours
31.28
-0.38(-1.20%)
- Real-time Data
  • Volume:
    1,255,592
  • Day's Range:
    29.68 - 32.21
  • 52 wk Range:
    28.21 - 187.85

TXG Overview

Prev. Close
29.31
Day's Range
29.68-32.21
Revenue
497.94M
Open
29.68
52 wk Range
28.21-187.85
EPS
-1.27
Volume
1,255,592
Market Cap
3.61B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,360,381
P/E Ratio
-38.02
Beta
1.66
1-Year Change
-78.32%
Shares Outstanding
113,913,621
Next Earnings Date
Nov 02, 2022
What is your sentiment on 10X Genomics?
or
Market is currently closed. Voting is open during market hours.

10X Genomics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

10X Genomics Inc Analysis

10X Genomics Inc Company Profile

10X Genomics Inc Company Profile

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Read More

Analyst Price Target

Average86.00 (+171.64% Upside)
High115
Low51
Price31.66
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
  • yet another Kathy stock going down the toilet
    0
    • such loss is not justified even if the company missed the revenue estimates, missed not that much...i think it is a fear moment on the market
      0
  • what's wrong with this stock?
    0
    • Fiyyaz Pirani makes luxury life with your money .! great.!
      0
      • This is way overpriced. Look at the earnings! why is it over 100? unless like Kathy wood who will keep the stock for 5 years.  Short this stock! This is not the time to buy speculative stocks! it will be under 100 soon!!
        4
        • this comment isn't aging well
          0
        • 😬😬😬
          0
      • guys, why premarket is going down so much? any idea?
        0
        • Welcome to this nice stock. I'm here since 64 pre pandemic
          0
          • wow! great gain
            0
          • that's your target pal, if I may ask? 220?
            0
          • good question, I dont know. But if look at Illumina, I think TXG can do more than 220.
            0
        • Well, obviously I put money 2 days ago and..
          0
          • Looksgreat
            0